版本:
中国

BRIEF-Akorn invalidates Durezol patent via inter partes review proceeding

Nov 28 Akorn Inc

* On November 22, 2016, patent trial and appeal board ruled in favor of Akorn in its inter partes review proceeding

* PTAB found all claims of 6.1 million patent related to Durezol formulation to be obvious Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐